Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival.

Arriaga JM, Levy EM, Bravo AI, Bayo SM, Amat M, Aris M, Hannois A, Bruno L, Roberti MP, Loria FS, Pairola A, Huertas E, Mordoh J, Bianchini M.

Hum Pathol. 2012 Feb;43(2):197-208. doi: 10.1016/j.humpath.2011.04.015. Epub 2011 Aug 4.

PMID:
21820154
2.

MT1G hypermethylation is associated with higher tumor stage in prostate cancer.

Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1274-8.

3.

The roles of JK-1 (FAM134B) expressions in colorectal cancer.

Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK.

Exp Cell Res. 2014 Aug 1;326(1):166-73. doi: 10.1016/j.yexcr.2014.06.013. Epub 2014 Jun 25.

PMID:
24973512
4.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
5.

Clinical significance of BMP7 in human colorectal cancer.

Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.

Ann Surg Oncol. 2008 May;15(5):1530-7. doi: 10.1245/s10434-007-9746-4. Epub 2008 Feb 8.

PMID:
18259822
6.

Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.

Paik SS, Jang KS, Song YS, Jang SH, Min KW, Han HX, Na W, Lee KH, Choi D, Jang SJ.

Ann Surg Oncol. 2007 Dec;14(12):3453-9. Epub 2007 Sep 20.

PMID:
17882496
7.

Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.

Alqurashi N, Gopalan V, Smith RA, Lam AK.

Hum Pathol. 2013 Oct;44(10):2089-96. doi: 10.1016/j.humpath.2013.03.014. Epub 2013 Jun 14.

PMID:
23773481
8.

Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.

Furlan D, Sahnane N, Carnevali I, Cerutti R, Bertoni F, Kwee I, Uccella S, Bertolini V, Chiaravalli AM, Capella C.

Hum Pathol. 2008 Oct;39(10):1483-94. doi: 10.1016/j.humpath.2008.02.013. Epub 2008 Jul 11.

PMID:
18619649
9.

Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.

Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post S, Jansen A, Colburn NH, Allgayer H.

Cancer. 2007 Oct 15;110(8):1697-707.

10.

Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.

Toyoda A, Kawana H, Azuhata K, Yu J, Omata A, Kishi H, Higashi M, Harigaya K.

Int J Oncol. 2009 Jan;34(1):53-60.

PMID:
19082477
11.

Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.

Tong JD, Jiao NL, Wang YX, Zhang YW, Han F.

Neoplasma. 2011;58(5):441-8.

PMID:
21744999
12.

Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.

Stallmach A, Wittig BM, Kremp K, Goebel R, Santourlidis S, Zeitz M, Menges M, Raedle J, Zeuzem S, Schulz WA.

Exp Mol Pathol. 2003 Jun;74(3):262-6.

PMID:
12782013
13.

Upregulation of activator protein-4 in human colorectal cancer with metastasis.

Cao J, Tang M, Li WL, Xie J, Du H, Tang WB, Wang H, Chen XW, Xiao H, Li Y.

Int J Surg Pathol. 2009 Feb;17(1):16-21. doi: 10.1177/1066896908315813. Epub 2008 May 14.

PMID:
18480385
14.

Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC.

Cancer Res. 1996 May 15;56(10):2422-7.

15.

Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.

Gertler R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, Siewert JR.

Cancer. 2002 Nov 15;95(10):2103-11.

16.

Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.

Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.

J Clin Gastroenterol. 2009 Oct;43(9):831-7. doi: 10.1097/MCG.0b013e31819cc731.

PMID:
19461527
17.
18.

Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.

Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DS.

Clin Cancer Res. 2004 Nov 15;10(22):7475-83.

19.

Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.

Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G, Adams JC.

BMC Cancer. 2006 Oct 9;6:241. Erratum in: BMC Cancer. 2011;11:488.

20.

Prognostic significance of metallothionein in human gastrointestinal cancer.

Janssen AM, van Duijn W, Kubben FJ, Griffioen G, Lamers CB, van Krieken JH, van de Velde CJ, Verspaget HW.

Clin Cancer Res. 2002 Jun;8(6):1889-96.

Supplemental Content

Support Center